LIPID HANDLING CONVEYS SENSITIVITY TO ANTI-BCMA IMMUNOTHERAPY IN MULTIPLE MYELOMA

被引：0
|
作者：
La Spina, E. [1 ]
Romano, A. [3 ]
Giallongo, C. [2 ]
Tibullo, D. [1 ]
Dulcamare, I.
Scuderi, E. [1 ]
Scandura, G. [3 ]
Cambria, D. [3 ]
Cortellino, S. [5 ]
Mecca, M. [5 ]
Picerno, S. [5 ]
Neri, A.
Amoresano, A. [4 ]
Pinto, G. [4 ]
Serpico, S. [4 ]
Sgambato, A.
Palumbo, G. A. [2 ]
Di Raimondo, F. [3 ]
机构：
[1] Univ Catania, Dept Biotechnol & Biomed Sci, Catania, Italy
[2] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Catania, Italy
[3] Univ Catania, Dept Surg & Med Specialties, Catania, Italy
[4] Univ Naples Federico II, Dept Chem Sci, Naples, Italy
[5] IRCCS, Referral Canc Ctr Basilicata, Lab Preclin & Translat Res, CROB, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P094
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [21] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
    Yao, Xin
    Zhu, Shigui
    Huang, Jiaqi
    Qu, Xiaoyan
    Zhu, Judy
    Wei, Yutian
    Lan, Liping
    Lv, Xiaoteng
    Wu, Junfeng
    Wang, Rirfei
    Yang, Dingzhu
    Zheng, Chengxiao
    Zhao, DiJun
    Fan, Lei
    Huang, Fei
    Lu, Hua
    Zhang, Chaocan
    Chen, Cheng
    Li, Yanfeng
    Ren, Jiaqiang
    Zhang, Li
    Humphries, Michael
    Li, Jianyong
    Yao, Yihong
    BLOOD, 2019, 134
  • [22] Infections and Severe Hypogammaglobulinemia in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies
    Lancman, Guido
    Parsa, Kian
    Rodriguez, Cesar
    Richter, Joshua
    Cho, Hearn J.
    Parekh, Samir
    Richard, Shambavi
    Rossi, Adriana
    Sanchez, Larysa
    Thibaud, Santiago
    Jagannath, Sundar
    Chari, Ajai
    BLOOD, 2022, 140 : 10073 - 10074
  • [23] Pseudoprogression in multiple myeloma patients treated with Anti-BCMA CAR-T cells
    Topp, Max
    Schimanski, Sven
    Hornburger, Hannah
    Kadel, Sophie
    Einsele, Hermann
    Rasche, Leo
    Duell, Johannes
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 146 - 146
  • [24] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Wang, Qingming
    Wei, Runhong
    Guo, Shufang
    Min, Chao
    Zhong, Xiong
    Huang, Hui
    Cheng, Zhi
    CANCER GENE THERAPY, 2024, 31 (01) : 108 - 118
  • [25] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Qingming Wang
    Runhong Wei
    Shufang Guo
    Chao Min
    Xiong Zhong
    Hui Huang
    Zhi Cheng
    Cancer Gene Therapy, 2024, 31 : 420 - 426
  • [26] Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells
    Chen, Haiming
    Li, Mingjie
    Xu, Ning
    Ng, Nicole
    Sanchez, Eric
    Soof, Camilia M.
    Patil, Saurabh
    Udd, Kyle
    Bujarski, Sean
    Cao, Jasmin
    Hekmati, Tara
    Ghermezi, Matthew
    Zhou, Mizi
    Wang, Emily Y.
    Tanenbaum, Edward J.
    Zahab, Brian
    Schlossberg, Remy
    Yashar, Moryel A.
    Wang, Cathy S.
    Tang, George Y.
    Spektor, Tanya M.
    Berenson, James R.
    LEUKEMIA RESEARCH, 2019, 81 : 62 - 66
  • [27] Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy
    Longcor, Jarrod
    Callander, Natalie
    Oliver, Kate
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    BLOOD CANCER JOURNAL, 2022, 12 (09)
  • [28] Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy
    Jarrod Longcor
    Natalie Callander
    Kate Oliver
    Asher Chanan-Khan
    Sikander Ailawadhi
    Blood Cancer Journal, 12
  • [29] The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
    Manjunath, Shwetha H.
    Cohen, Adam D.
    Lacey, Simon F.
    Davis, Megan M.
    Garfall, Alfred L.
    Melenhorst, J. Joseph
    Maxwell, Russell
    Arscott, W. Tristram
    Maity, Amit
    Jones, Joshua A.
    Plastaras, John P.
    Stadtmauer, Edward A.
    Levine, Bruce L.
    June, Carl H.
    Milone, Michael C.
    Paydar, Ima
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6580 - 6590
  • [30] Efficacy and Safety of Cilta-Cel in Patients with Progressive Multiple Myeloma after Exposure to Non-Cellular Anti-BCMA Immunotherapy
    Cohen, Adam D.
    Mateos, Maria-Victoria
    Cohen, Yael C.
    Rodriguez Otero, Paula
    Paiva, Bruno
    Van de Donk, Niels W. C. J.
    Martin, Thomas
    Suvannasankha, Attaya
    Corsale, Christina
    Schecter, Jordan M.
    De Braganca, Kevin C.
    Jackson, Carolyn C.
    Varsos, Helen
    Deraedt, William
    Roccia, Tito
    Mistry, Pankaj
    Xu, Xiaoying
    Li, Katherine
    Zudaire, Enrique
    Akram, Muhammad
    Pacaud, Lida
    Avivi, Irit
    San-Miguel, Jesus
    BLOOD, 2022, 140 : 4646 - 4648
12345